These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35730907)

  • 1. Dynamic incorporation of real world evidence within the framework of adaptive design.
    Lin J; Liao R; Gamalo-Siebers M
    J Biopharm Stat; 2022 Nov; 32(6):986-998. PubMed ID: 35730907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic use of historical controls in clinical trials for rare disease research: A re-evaluation of the MILES trial.
    Harun N; Gupta N; McCormack FX; Macaluso M
    Clin Trials; 2023 Jun; 20(3):223-234. PubMed ID: 36927115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BEATS: Bayesian hybrid design with flexible sample size adaptation for time-to-event endpoints.
    Bi D; Liu M; Lin J; Liu R
    Stat Med; 2023 Dec; 42(30):5708-5722. PubMed ID: 37858287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covariate handling approaches in combination with dynamic borrowing for hybrid control studies.
    Fu C; Pang H; Zhou S; Zhu J
    Pharm Stat; 2023; 22(4):619-632. PubMed ID: 36882191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control.
    Harun N; Liu C; Kim MO
    Pharm Stat; 2020 Sep; 19(5):613-625. PubMed ID: 32185886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical data.
    Liu M; Bunn V; Hupf B; Lin J; Lin J
    Stat Med; 2021 Sep; 40(22):4794-4808. PubMed ID: 34126656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Power prior for borrowing the real-world data in bioequivalence test with a parallel design.
    Huang L; Su L; Zheng Y; Chen Y; Yan F
    Int J Biostat; 2021 May; 18(1):73-82. PubMed ID: 33962492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian adaptive randomization design incorporating propensity score-matched historical controls.
    Sawamoto R; Oba K; Matsuyama Y
    Pharm Stat; 2022 Sep; 21(5):1074-1089. PubMed ID: 35278032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporating propensity scores for evidence synthesis under bayesian framework: review and recommendations for clinical studies.
    Lin J; Lin J
    J Biopharm Stat; 2022 Jan; 32(1):53-74. PubMed ID: 33998364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propensity score-integrated Bayesian prior approaches for augmented control designs: a simulation study.
    Wang X; Suttner L; Jemielita T; Li X
    J Biopharm Stat; 2022 Jan; 32(1):170-190. PubMed ID: 34939894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample size re-estimation for response-adaptive randomized clinical trials.
    Li X; Hu F
    Pharm Stat; 2022 Sep; 21(5):1058-1073. PubMed ID: 35191605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of propensity score-based Bayesian borrowing of external adult data in pediatric trials: A pragmatic evaluation through a case study in acute lymphoblastic leukemia (ALL).
    Majumdar A; Rothwell R; Reaman G; Ahlberg C; Roy P
    J Biopharm Stat; 2023 Nov; 33(6):737-751. PubMed ID: 36600441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional borrowing external data to establish a hybrid control arm in randomized clinical trials.
    Li H; Tiwari R; Li QH
    J Biopharm Stat; 2022 Nov; 32(6):954-968. PubMed ID: 35067183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Improved Matching Practice for Augmenting a Randomized Clinical Trial with External Control.
    Li J; Du Y; Liu H; Yi Y
    Ther Innov Regul Sci; 2023 May; 57(3):611-618. PubMed ID: 36809484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive design implementation in confirmatory trials: methods, practical considerations and case studies.
    Li Q; Lin J; Lin Y
    Contemp Clin Trials; 2020 Nov; 98():106096. PubMed ID: 32739496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matching within a hybrid RCT/RWD: framework on associated causal estimands.
    Lin J; Yu G; Gamalo M
    J Biopharm Stat; 2023 Jul; 33(4):439-451. PubMed ID: 35929973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size re-estimation in adaptive enrichment design.
    Lin R; Yang Z; Yuan Y; Yin G
    Contemp Clin Trials; 2021 Jan; 100():106216. PubMed ID: 33246098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine clinical trials with dynamic borrowing of historical controls: Two retrospective studies.
    Callegaro A; Karkada N; Aris E; Zahaf T
    Pharm Stat; 2023; 22(3):475-491. PubMed ID: 36606496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Power priors with entropy balancing weights in data augmentation of partially controlled randomized trials.
    Yu G; Bian Y; Gamalo M
    J Biopharm Stat; 2022 Jan; 32(1):4-20. PubMed ID: 35072583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.